In Medicines Co. v. Hospira, Inc., 827 F.3d 1363 (Fed. Cir. 2016) (en banc), the United States filed an amicus brief, signed by the U.S. Patent and Trademark Office\u27s (PTO) Solicitor and attorneys in the Department of Justice, in support of the plaintiff-appellant. Among other things, the government argued that secret sales should not trigger the on-sale bar within the meaning of § 102 of the Patent Act applying to patents governed by the regime prior to the Leahy-Smith America Invents Act. While government amicus filings in patent infringement cases are not uncommon, this brief is notable because it explicitly disavowed case law that is both binding on the PTO and unfavorable to patent applicants. In fact, the government acknowledged th...
The failure to require the patent bar to be completely candid in its dealings with the U.S. Patent a...
Last week, the U.S. Supreme Court upheld the constitutionality of certain adjudications of patent ri...
Whereas Congress has increasingly turned to administrative agencies to regulate complex technical ar...
In Medicines Co. v. Hospira, Inc., 827 F.3d 1363 (Fed. Cir. 2016) (en banc), the United States filed...
Many patent applications are rejected upon initial submission, but they are almost never rejected wi...
One of the most divisive and debated issues in patent law in recent years has been the Patent Office...
To those unfamiliar with the long, often bitter, struggle over equally compelling needs to provide, ...
Among federal agencies, the U. S. Patent and Trademark Office is unique in its ability to require at...
Interactions between the PTO and the courts are more complex than for most agencies. PTO decisions m...
In Consumer Watchdog v. Wisconsin Alumni Research Foundation, the Court of Appeals for the Federal ...
Among patent scholars who address institutional questions, many favor the courts over the PTO as the...
For more than two decades, the Patent and Trademark Office (PTO) and the Federal Circuit have exerci...
This Article examines the possible inequity of the treatment of licensees\u27 rights in tort litigat...
In Consumer Watchdog v. Wisconsin Alumni Research Foundation, the Court of Appeals for the Federal C...
Increasingly, accused infringers challenge a patent’s validity in two different forums: in litigatio...
The failure to require the patent bar to be completely candid in its dealings with the U.S. Patent a...
Last week, the U.S. Supreme Court upheld the constitutionality of certain adjudications of patent ri...
Whereas Congress has increasingly turned to administrative agencies to regulate complex technical ar...
In Medicines Co. v. Hospira, Inc., 827 F.3d 1363 (Fed. Cir. 2016) (en banc), the United States filed...
Many patent applications are rejected upon initial submission, but they are almost never rejected wi...
One of the most divisive and debated issues in patent law in recent years has been the Patent Office...
To those unfamiliar with the long, often bitter, struggle over equally compelling needs to provide, ...
Among federal agencies, the U. S. Patent and Trademark Office is unique in its ability to require at...
Interactions between the PTO and the courts are more complex than for most agencies. PTO decisions m...
In Consumer Watchdog v. Wisconsin Alumni Research Foundation, the Court of Appeals for the Federal ...
Among patent scholars who address institutional questions, many favor the courts over the PTO as the...
For more than two decades, the Patent and Trademark Office (PTO) and the Federal Circuit have exerci...
This Article examines the possible inequity of the treatment of licensees\u27 rights in tort litigat...
In Consumer Watchdog v. Wisconsin Alumni Research Foundation, the Court of Appeals for the Federal C...
Increasingly, accused infringers challenge a patent’s validity in two different forums: in litigatio...
The failure to require the patent bar to be completely candid in its dealings with the U.S. Patent a...
Last week, the U.S. Supreme Court upheld the constitutionality of certain adjudications of patent ri...
Whereas Congress has increasingly turned to administrative agencies to regulate complex technical ar...